Lv2
110 积分 2023-12-02 加入
Recent Advance of Hypoxia-Inducible Factor Prolyl Hydroxylases inhibitors for Anemia Therapy
4个月前
已完结
Lupus Nephritis: Unmet Needs and Evolving Solutions
4个月前
已完结
Genetic susceptibility to membranous lupus nephritis: a genome-wide association study
4个月前
已完结
Advances in the treatment of systemic lupus erythematosus
5个月前
已完结
Sirolimus versus mycophenolate mofetil for the treatment of lupus nephritis: Results from a real-world CSTAR cohort study
5个月前
已完结
Real world data on dual BLyS/APRIL inhibition with telitacicept for lupus nephritis
5个月前
已完结
Clinical Implications of a New DDX58 Pathogenic Variant That Causes Lupus Nephritis due to RIG-I Hyperactivation
5个月前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
5个月前
已完结
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
5个月前
已完结
Efficacy, safety, and optimal intervention of belimumab for proliferative lupus nephritis patients in real-world settings: LOOPS registry
5个月前
已完结
皖公网安备34019202002308
